Gastroenterology

Texas Children's Announces Physician Leadership Team at North Austin Campus

Retrieved on: 
Thursday, January 25, 2024

"We are honored to bring such amazing talent to our hospital," said Russ Williams , Senior Vice President of Texas Children's North Austin Campus.

Key Points: 
  • "We are honored to bring such amazing talent to our hospital," said Russ Williams , Senior Vice President of Texas Children's North Austin Campus.
  • A past winner of the Most Valuable Physician award at St. David's South Austin Medical Center, she is thrilled to bring her expertise to Texas Children's Hospital North Austin.
  • With these new appointments, Texas Children's Hospital North Austin Campus is ready to expand that tradition of exceptional care for children and women in Austin."
  • Located at 9835 North Lake Creek Parkway, Texas Children's North Austin will connect patients and families to Texas Children's numerous subspecialties including cardiology, oncology, neurology, pulmonology, gastroenterology, rheumatology, fetal care and more.

Specialty Networks Unveils the PPS Analytics Platform for Rheumatology to Enhance Patient Care and Practice Efficiency

Retrieved on: 
Wednesday, January 24, 2024

CLEVELAND, Jan. 24, 2024 /PRNewswire/ -- Specialty Networks, a provider of urology, gastroenterology, and rheumatology care performance and population management solutions for community-based specialty practices, has launched their technology and services platform, PPS Analytics, to United Rheumatology members. United Rheumatology was acquired by Specialty Networks in 2022.

Key Points: 
  • CLEVELAND, Jan. 24, 2024 /PRNewswire/ -- Specialty Networks , a provider of urology, gastroenterology, and rheumatology care performance and population management solutions for community-based specialty practices, has launched their technology and services platform, PPS Analytics, to United Rheumatology members.
  • United Rheumatology was acquired by Specialty Networks in 2022.
  • PPS Analytics is an AI-enabled technology platform designed to help identify, navigate, and engage patients to improve adherence to clinical care pathways and protocols for diagnostics and therapeutic interventions.
  • We are quite excited to launch PPS Analytics to our United Rheumatology member practices."

GI Alliance Expands East Coast Presence with Rhode Island GI Partnership

Retrieved on: 
Tuesday, January 23, 2024

DALLAS, Jan. 23, 2024 /PRNewswire/ -- GI Alliance, the nation's premier independent gastroenterology management organization, is pleased to announce a partnership with some of the most preeminent private practice gastroenterologists in Rhode Island, expanding GI Alliance's presence in the Northeast.

Key Points: 
  • DALLAS, Jan. 23, 2024 /PRNewswire/ -- GI Alliance, the nation's premier independent gastroenterology management organization, is pleased to announce a partnership with some of the most preeminent private practice gastroenterologists in Rhode Island, expanding GI Alliance's presence in the Northeast.
  • University Gastroenterology, Gastroenterology Associates, and Gastrointestinal Medicine Associates have been working together to provide better access to patients across Rhode Island and surrounding areas.
  • GI Alliance's partnership with these physicians will expand coverage for patients throughout New England.
  • "These physicians are some of the highest quality doctors throughout the nation, and GI Alliance is privileged to partner with these practices," said Jim Weber, M.D., CEO of GI Alliance.

CU Anschutz Announces Awardees for the Anschutz Acceleration Initiative

Retrieved on: 
Thursday, January 18, 2024

AURORA, Colo., Jan. 18, 2024 /PRNewswire/ -- The University of Colorado Anschutz Medical Campus announced the grant awards for the Anschutz Acceleration Initiative, a program focused on advancing cutting-edge healthcare innovations poised to reach patients within three to five years.

Key Points: 
  • The initiative was made possible by a $50 million gift from The Anschutz Foundation , a longtime philanthropic campus partner focused on bringing the innovative work at CU Anschutz to the forefront of patient care.
  • "The Anschutz Foundation has championed the people and programs that drive innovation here," said CU Anschutz Chancellor Donald M. Elliman.
  • The CU Anschutz faculty, whom the Anschutz Acceleration Initiative will fund, represent a range of expertise that spans disciplines including oncology, dermatology, gastroenterology, ophthalmology, pharmacology, dental medicine, and more.
  • To read more about the initiative and the awardees, visit the Anschutz Acceleration Initiative website .

Leading Los Angeles Gastroenterologist Dr. David Yamini is Recognized by Los Angeles Magazine on their 2024 "Top Doctor" List

Retrieved on: 
Tuesday, January 16, 2024

SANTA MONICA, Calif., Jan. 16, 2024 /PRNewswire-PRWeb/ -- In a remarkable acknowledgment of professional excellence, Dr. David Yamini, a distinguished gastroenterologist and hepatologist, has been named to Los Angeles Magazine's esteemed "Top Doctor" list for 2024. This recognition underscores Dr. Yamini's profound commitment and exceptional contributions to the field of gastroenterology.

Key Points: 
  • SANTA MONICA, Calif., Jan. 16, 2024 /PRNewswire-PRWeb/ -- In a remarkable acknowledgment of professional excellence, Dr. David Yamini, a distinguished gastroenterologist and hepatologist , has been named to Los Angeles Magazine's esteemed "Top Doctor" list for 2024.
  • Dr. Yamini expressed his gratitude: "Being named to the 'Top Doctor' list once again is a great honor.
  • The selection for the "Top Doctor" list by Los Angeles Magazine is a rigorous process overseen by Professional Research Services (PRS).
  • Upon receiving this honor, Dr. Yamini expressed his gratitude: "Being named to the 'Top Doctor' list once again is a great honor.

New Global Observatory Survey Shows US Healthcare Providers Can Do More to Educate Patients on the Microbiota

Retrieved on: 
Tuesday, January 16, 2024

BEDMINSTER, N.J., Jan. 16, 2024 /PRNewswire-PRWeb/ -- Made up of billions of microorganisms, the human microbiota plays a vital role in health and overall wellbeing, including essential body functions like digestion, urinary tract health, weight, vaginal health and more. However, a new study by the Biocodex Microbiota Institute and Ipsos, which included 1,000 U.S. adults as part of a global survey, found that less than half of Americans understand what the microbiome is. This corresponds closely with the fact that more than half of U.S. respondents also said they have not received information about the microbiome from their healthcare provider (includes physicians, physician assistants and nurse practitioners).

Key Points: 
  • We see this as an opportunity for medical professionals to raise awareness about the opportunity to support a healthy microbiota.
  • In the US, patient education is key to explaining both the role of the microbiota and the behaviors needed to best preserve them.
  • Only 1 in 4 Americans has ever had the role of their microbiota explained to them by their healthcare professional.
  • Family physicians are the main healthcare providers who provide information about microbiome with gastroenterologists coming in next, but to a lesser extent.

EQS-News: Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

Retrieved on: 
Saturday, January 13, 2024

BERKELEY, US – MAINZ, Germany – January 11, 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in early cancer detection, re-affirms its collaboration with TestDNA at the upcoming 10th Gdańsk Gastroenterology Symposium on January 12th–13th, 2024.

Key Points: 
  • BERKELEY, US – MAINZ, Germany – January 11, 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in early cancer detection, re-affirms its collaboration with TestDNA at the upcoming 10th Gdańsk Gastroenterology Symposium on January 12th–13th, 2024.
  • The companies joined forces to advance innovative colorectal cancer (CRC) detection in Poland and to increase treatment options as well as survival rates through early detection.
  • The 10th Gdańsk Gastroenterology Symposium gathers national Polish lecturers, scientists, and practitioners who will share the latest insights in gastroenterology, hepatology, and gastrointestinal endoscopy.
  • Mainz Biomed and TestDNA will be present as exhibitor during the two day symposium, also they will open the second day of panel discussions.

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

Retrieved on: 
Thursday, January 11, 2024

BERKELEY, Calif. and MAINZ, Germany, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in early cancer detection, re-affirms its collaboration with TestDNA at the upcoming 10th Gdańsk Gastroenterology Symposium on January 12th–13th, 2024.

Key Points: 
  • BERKELEY, Calif. and MAINZ, Germany, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in early cancer detection, re-affirms its collaboration with TestDNA at the upcoming 10th Gdańsk Gastroenterology Symposium on January 12th–13th, 2024.
  • The companies joined forces to advance innovative colorectal cancer (CRC) detection in Poland and to increase treatment options as well as survival rates through early detection.
  • The 10th Gdańsk Gastroenterology Symposium gathers national Polish lecturers, scientists, and practitioners who will share the latest insights in gastroenterology, hepatology, and gastrointestinal endoscopy.
  • Mainz Biomed and TestDNA will be present as exhibitor during the two day symposium, they will also open the second day of panel discussions.

STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara

Retrieved on: 
Wednesday, January 10, 2024

Biosimilar competition in the €2.5 billion (US$2.7 billion) EU ustekinumab market could significantly expand patient access to this life-changing biologic therapy within gastroenterology, dermatology, and rheumatology.

Key Points: 
  • Biosimilar competition in the €2.5 billion (US$2.7 billion) EU ustekinumab market could significantly expand patient access to this life-changing biologic therapy within gastroenterology, dermatology, and rheumatology.
  • STADA’s Global Specialty Head, Bryan Kim, commented: “This first marketing authorization for biosimilar ustekinumab in Europe offers the potential to expand substantially patient access through competition.
  • Under a strategic partnership begun in 2019, Alvotech is primarily responsible for developing and manufacturing the AVT04 ustekinumab biosimilar.
  • These include a high-concentration, citrate-free adalimumab biosimilar developed and marketed through the partnership between Alvotech and STADA.

United Digestive Implements Innovative Education Program from Boston Scientific

Retrieved on: 
Thursday, January 11, 2024

ATLANTA, Jan. 11, 2024 /PRNewswire/ -- United Digestive, a leading provider of gastroenterology (GI) services and one of the largest GI physician practice management platforms in the U.S., has introduced a personalized education program powered by Boston Scientific. Known as the GI Foundations Program, this initiative underscores United Digestive's dedication to advancing gastroenterology by providing its providers and ancillary teams unparalleled access to new endoscopic educational programs.

Key Points: 
  • ATLANTA, Jan. 11, 2024 /PRNewswire/ -- United Digestive , a leading provider of gastroenterology (GI) services and one of the largest GI physician practice management platforms in the U.S., has introduced a personalized education program powered by Boston Scientific.
  • United Digestive was the inaugural organization to implement the GI Foundations Program across all 22 of its state-of-the-art Endoscopy Centers.
  • As part of the Boston Scientific EDUCARE online platform, the GI Foundations Program offers self-paced online learning, hands-on practice, and access to additional clinical and non-clinical education opportunities.
  • Through the implementation of this educational program, United Digestive aims to create an environment that empowers providers and staff to prioritize patient care by enhancing clinical standards.